Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Cornelissen

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|March 31, 2018
Heterogeneity in Immune Cell Content in Malignant Pleural MesotheliomaJorien Minnema-Luiting, Heleen Vroman, Joachim Aerts, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2018
Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challengeLuana Calabrò, Aldo Morra, Robin Cornelissen, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2017
Checkpoint Blockade in Lung Cancer and MesotheliomaLysanne A Lievense, Daniel H Sterman, Robin Cornelissen, et al.
Multimedia Manual of Cardiothoracic Surgery : MMCTS|July 8, 2020
Video-assisted biopsy and talc pleurodesis for malignant pleural mesotheliomaAlexander Maat, Saya Abdullah, Geerten Schouten, et al.
Immunotherapy|May 6, 2017
Immunotherapeutic strategies in non-small-cell lung cancer: the present and the futureChristi M Steendam, Floris Dammeijer, Joachim G J V Aerts, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 19, 2019
Endovascular Coils as Lung Tumor Fiducial Markers for Real-Time Tumor Tracking in Stereotactic Body Radiotherapy: Comparison of Complication Rates with Transthoracic Fiducial Marker PlacementSarah Baker, Aman Sharma, Imogeen Antonisse, et al.
Vaccines|June 2, 2021
Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II TrialsDaphne W Dumoulin, Robin Cornelissen, Koen Bezemer, et al.
Frontiers in Oncology|November 16, 2020
Differentiation of COVID-19 Pneumonitis and ICI Induced PneumonitisDaphne W Dumoulin, Hester A Gietema, Marthe S Paats, et al.
Future Oncology (London, England)|December 8, 2015
Is the patient with mesothelioma without hope?Alexander P W M Maat, Robin Cornelissen, Ad J J C Bogers, et al.
BMC Cancer|December 11, 2012
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatmentMarlies E Heuvers, Joachim G Aerts, Robin Cornelissen, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|March 31, 2018
Heterogeneity in Immune Cell Content in Malignant Pleural MesotheliomaJorien Minnema-Luiting, Heleen Vroman, Joachim Aerts, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2018
Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challengeLuana Calabrò, Aldo Morra, Robin Cornelissen, et al.
American Journal of Respiratory and Critical Care Medicine|March 3, 2017
Checkpoint Blockade in Lung Cancer and MesotheliomaLysanne A Lievense, Daniel H Sterman, Robin Cornelissen, et al.
Multimedia Manual of Cardiothoracic Surgery : MMCTS|July 8, 2020
Video-assisted biopsy and talc pleurodesis for malignant pleural mesotheliomaAlexander Maat, Saya Abdullah, Geerten Schouten, et al.
Immunotherapy|May 6, 2017
Immunotherapeutic strategies in non-small-cell lung cancer: the present and the futureChristi M Steendam, Floris Dammeijer, Joachim G J V Aerts, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 19, 2019
Endovascular Coils as Lung Tumor Fiducial Markers for Real-Time Tumor Tracking in Stereotactic Body Radiotherapy: Comparison of Complication Rates with Transthoracic Fiducial Marker PlacementSarah Baker, Aman Sharma, Imogeen Antonisse, et al.
Vaccines|June 2, 2021
Long-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II TrialsDaphne W Dumoulin, Robin Cornelissen, Koen Bezemer, et al.
Frontiers in Oncology|November 16, 2020
Differentiation of COVID-19 Pneumonitis and ICI Induced PneumonitisDaphne W Dumoulin, Hester A Gietema, Marthe S Paats, et al.
Future Oncology (London, England)|December 8, 2015
Is the patient with mesothelioma without hope?Alexander P W M Maat, Robin Cornelissen, Ad J J C Bogers, et al.
BMC Cancer|December 11, 2012
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatmentMarlies E Heuvers, Joachim G Aerts, Robin Cornelissen, et al.
Pageof 6